Validation of Novel Therapeutic Targets for Huntingtons Disease (R01)

The summary for the Validation of Novel Therapeutic Targets for Huntingtons Disease (R01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


Federal Grant Title: Validation of Novel Therapeutic Targets for Huntingtons Disease (R01)
CFDA Number: 93.853
CFDA Description: Extramural Research Programs in the Neurosciences and Neurological Disorders
Federal Agency Name: National Institutes of Health
Category of Funding Activity: Health
Category Explanation: Information not provided
Opportunity Category: Discretionary
Funding Opportunity Number: PAS-10-183
Document Type: Grants Notice
Funding Instrument Type: Grant
Posted Date: Apr 30, 2010
Creation Date: Apr 30, 2010
Original Closing Date for Applications: May 07, 2013
Current Closing Date for Applications: May 07, 2013
Archive Date: Jun 07, 2013
Expected Number of Awards: Information not provided
Estimated Total Program Funding: $4,500,000
Federal Grant Award Ceiling: Information not provided
Federal Grant Award Floor: Information not provided
Cost Sharing or Matching Requirement: No

Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Grant Description
Purpose. The National Institute of Neurological Disorders and Stroke (NINDS) invites research project grant (R01) applications aimed at validating novel molecular targets for disease-modifying therapeutic intervention in Huntingtons disease. This FOA is for support of new projects, and not the continuation of projects that have already been initiated with NIH funding. Mechanism of Support. This FOA will utilize the R01 grant mechanism. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. $4,500,000 has been set aside in fiscal year 2011 for support of 3 to 4 R01 research projects (assuming average direct costs of $250,000 per year and an average length of four years) in addition to those funded within NINDS regular funding policies. In subsequent years, the amount available will be contingent upon the availability of funds and will be announced in Notices published in the NIH Guide to Grants and Contracts.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/pas-10-183.html
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
NINDS Research Education Programs for Residents and Fellows in Neurology, Neurosurgery, Neuropatholo...
Exceptional, Unconventional Research Enabling Knowledge Acceleration (EUREKA) In the Epilepsies (R01...
Spinal Muscular Atrophy (SMA) Biomarker Study (U01)
Limited Competition for Continuation of Induced Pluripotent Stem Cell (iPSC) Resources promoting Tra...
Limited Competition for the Continuation of Rare Diseases Clinical Research Consortia in the Rare Di...
NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44)
NINDS Institutional Center Core Grants to Support Neuroscience Research
Career Development Award to Promote Diversity in Neuroscience Research
Specialized Program of Translational Research in Acute Stroke
NINDS Cooperative Program in Translational Research

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2012 FederalGrants.com